Li Watsek
Stock Analyst at Cantor Fitzgerald
(0.32)
# 4,463
Out of 4,693 analysts
121
Total ratings
42.2%
Success rate
-6.5%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Li Watsek
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| NUVB Nuvation Bio | Initiated Coverage: Buy | $12 | $6.64 | +80.72% | 1 | Aug 21, 2026 | |
| ASND Ascendis Pharma | Reiterated: Buy | $300 | $260.25 | +15.27% | 26 | Aug 14, 2026 | |
| ZLAB Zai Lab | Maintained: Buy | $37 | $25.30 | +46.25% | 9 | Aug 6, 2026 | |
| REPL Replimune Group | Upgraded: Buy | n/a | $15.67 | - | 6 | Jul 31, 2026 | |
| ANL Adlai Nortye Group | Maintained: Buy | n/a | $13.63 | - | 2 | Jul 16, 2026 | |
| IMRX Immuneering | Initiated Coverage: Buy | $17 | $4.85 | +250.52% | 1 | Jul 8, 2026 | |
| FTH Faeth Therapeutics | Maintained: Buy | n/a | $34.51 | - | 2 | Jun 3, 2026 | |
| CRIS Curis | Rated: Hold | n/a | $1.42 | - | 4 | Mar 27, 2026 | |
| TYRA Tyra Biosciences | Maintained: Buy | n/a | $25.30 | - | 2 | Mar 4, 2026 | |
| AVBP ArriVent BioPharma | Initiated Coverage: Buy | n/a | $30.15 | - | 1 | Dec 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | n/a | $2.31 | - | 1 | Dec 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $29.71 | - | 6 | Oct 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | n/a | $0.3643 | - | 1 | Oct 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $9.28 | - | 6 | Sep 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $39.95 | - | 2 | Sep 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $12.89 | n/a | 8 | Jun 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $14.27 | n/a | 8 | Jun 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $2.07 | n/a | 3 | May 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $0.000001 | n/a | 3 | May 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | n/a | $3.90 | n/a | 1 | Mar 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $1.98 | n/a | 6 | Jan 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $4.10 | n/a | 5 | Jun 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $11 | $0.1745 | n/a | 4 | Aug 30, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $5 | $2.43 | n/a | 5 | Aug 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $8 → $5 | $0.0131 | n/a | 3 | Aug 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $71 → $38 | $2.70 | n/a | 2 | Aug 12, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $16 → $6 | $13.22 | n/a | 3 | Jun 28, 2022 |
Nuvation Bio
Aug 21, 2026
Initiated Coverage: Buy
Price Target: $12
Current: $6.64
Upside: +80.72%
Ascendis Pharma
Aug 14, 2026
Reiterated: Buy
Price Target: $300
Current: $260.25
Upside: +15.27%
Zai Lab
Aug 6, 2026
Maintained: Buy
Price Target: $37
Current: $25.30
Upside: +46.25%
Replimune Group
Jul 31, 2026
Upgraded: Buy
Price Target: n/a
Current: $15.67
Upside: -
Adlai Nortye Group
Jul 16, 2026
Maintained: Buy
Price Target: n/a
Current: $13.63
Upside: -
Immuneering
Jul 8, 2026
Initiated Coverage: Buy
Price Target: $17
Current: $4.85
Upside: +250.52%
Faeth Therapeutics
Jun 3, 2026
Maintained: Buy
Price Target: n/a
Current: $34.51
Upside: -
Curis
Mar 27, 2026
Rated: Hold
Price Target: n/a
Current: $1.42
Upside: -
Tyra Biosciences
Mar 4, 2026
Maintained: Buy
Price Target: n/a
Current: $25.30
Upside: -
ArriVent BioPharma
Dec 22, 2025
Initiated Coverage: Buy
Price Target: n/a
Current: $30.15
Upside: -
Dec 3, 2025
Initiated Coverage: Buy
Price Target: n/a
Current: $2.31
Upside: -
Oct 8, 2025
Reiterated: Buy
Price Target: n/a
Current: $29.71
Upside: -
Oct 2, 2025
Initiated Coverage: Buy
Price Target: n/a
Current: $0.3643
Upside: -
Sep 18, 2025
Reiterated: Buy
Price Target: n/a
Current: $9.28
Upside: -
Sep 9, 2025
Reiterated: Buy
Price Target: n/a
Current: $39.95
Upside: -
Jun 26, 2025
Reiterated: Buy
Price Target: n/a
Current: $12.89
Upside: n/a
Jun 12, 2025
Reiterated: Buy
Price Target: n/a
Current: $14.27
Upside: n/a
May 15, 2025
Reiterated: Buy
Price Target: n/a
Current: $2.07
Upside: n/a
May 14, 2025
Downgraded: Hold
Price Target: n/a
Current: $0.000001
Upside: n/a
Mar 14, 2025
Initiated Coverage: Buy
Price Target: n/a
Current: $3.90
Upside: n/a
Jan 24, 2025
Reiterated: Buy
Price Target: n/a
Current: $1.98
Upside: n/a
Jun 3, 2024
Reiterated: Buy
Price Target: n/a
Current: $4.10
Upside: n/a
Aug 30, 2023
Maintained: Buy
Price Target: $11
Current: $0.1745
Upside: n/a
Aug 9, 2023
Reiterated: Hold
Price Target: $5
Current: $2.43
Upside: n/a
Aug 7, 2023
Reiterated: Buy
Price Target: $8 → $5
Current: $0.0131
Upside: n/a
Aug 12, 2022
Maintained: Buy
Price Target: $71 → $38
Current: $2.70
Upside: n/a
Jun 28, 2022
Maintained: Buy
Price Target: $16 → $6
Current: $13.22
Upside: n/a